About Technology Issues FAQ

Links

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.